Faes Farma (Faes Farma) EV-to-Revenue : 1.89 (As of May. 26, 2024)

View and export this data going back to . Start your Free Trial

What is Faes Farma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Faes Farma's enterprise value is $882.96 Mil. Faes Farma's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $465.95 Mil. Therefore, Faes Farma's EV-to-Revenue for today is 1.89.

The historical rank and industry rank for Faes Farma's EV-to-Revenue or its related term are showing as below:

FSXMF' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.95 Med: 2.74 Max: 15.37
Current: 2.54

During the past 13 years, the highest EV-to-Revenue of Faes Farma was 15.37. The lowest was 1.95. And the median was 2.74.

FSXMF's EV-to-Revenue is ranked worse than
53.42% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs FSXMF: 2.54

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Faes Farma's stock price is $0.00. Faes Farma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $1.76. Therefore, Faes Farma's PS Ratio for today is 0.00.

Faes Farma EV-to-Revenue Historical Data

The historical data trend for Faes Farma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma EV-to-Revenue Chart

Faes Farma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

3.72

2.37

2.42

2.33

Faes Farma Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															2.64	2.33	2.17	2.17	-

Competitive Comparison of Faes Farma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Faes Farma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Faes Farma's EV-to-Revenue falls into.

Faes Farma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Faes Farma's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	882.961	/	465.952
	=	1.89

Faes Farma's current Enterprise Value is $882.96 Mil.
Faes Farma's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $465.95 Mil.

Faes Farma (OTCPK:FSXMF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Faes Farma's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.00	/	1.759
	=	0.00

Faes Farma's share price for today is $0.00.
Faes Farma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.76.

Faes Farma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Faes Farma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Faes Farma (Faes Farma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (OTCPK:FSXMF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

0K9H:UK FAE:Spain FFEA:Germany

Address

Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940

Website

http://www.faes.es

Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (Faes Farma) Headlines

No Headlines